<?xml version="1.0" encoding="UTF-8"?>
<p id="par0155">The criteria of this guidance for CCP treatment have been determined based on the current literature with the contributions of Turkish scientists Inittialy, CCP is recommended to the confirmed (PCR positive) or probable (clinical/radiological evidence compatible with COVID-19, but PCR test result not yet available) cases with COVID-19 infection who are above 18 years old within the first 14 days of the disease and 7â€“10 days after the symptoms started. It is not recommended beyond 14 days of the disease and the initiation of cytokine storm CCP should not be used in IgA-deficient patients. In case, IgA levels should be tested before the administration of CCP.</p>
